You are here
SPINEWAY :Spineway sets up the governing structure for its US subsidiary
Press release Ecully, 15 November 2018
Spineway sets up the governing structure for its US subsidiary
Appointment of Jon Luedke as CEO
Spineway, specialist in surgical implants and instruments for treating disorders of the spinal column (spine), is reorganizing and setting up the governing structure for its US subsidiary with the arrival of a new CEO.
Pursuant to the strategic plan, Stéphane Le Roux, CEO of Spineway SA, launched the reorganization of the US subsidiary in order to revitalize sales in said country. The first steps are the arrival of Jon Luedke as CEO of Spineway Inc. and Philippe Laurito moving to the position of CTO. He will perform his duties within the subsidiary until the end of the year so as to ensure a smooth transition for the new CEO and provide technical follow-up on current business.
Jon Luedke, 54 years old, has over 20 years' experience in the spine sector. He has held positions as General Manager and Sales Manager with major groups (Zimmer Spine and Centinel Spine) and with innovative SMEs (Wenzel Spine and Prosidyan). During the course of his professional career, he was able to draw on his business-development skills to carry out projects from repositioning companies to reviving business activities, making it possible to improve the sales and profitability of the companies under his stewardship.
His thorough understanding of the spinal-column business and his knowledge of the various players on the US market will be an asset to the Group's new strategy, make it possible to market competitive products via the various distribution networks in the US.
The new momentum generated as a result of this appointment should allow the Group to create a new growth model for Spineway Inc.
SPINEWAY IS ELIGIBLE FOR THE PEA-PME (EQUITY SAVINGS PLANS FOR SMES)
Find out all about Spineway at www.spineway.com
Meeting for the presentation of the strategic plan on 13 December 2018
This press release has been prepared in both English and French. In case of discrepancies, the French version shall prevail.
Spineway designs, manufactures and markets innovative implants and surgical instruments for treating severe disorders of the spinal column.
Spineway has an international network of over 50 independent distributors and 90% of its revenue comes from exports.
Spineway, which is eligible for investment through FCPIs (French unit trusts specializing in innovation), has received the OSEO Excellence award since 2011 and has won the Deloitte Fast 50 award (2011). Rhône Alpes INPI Patent Innovation Award (2013) - INPI Talent award (2015). ISIN: FR0011398874 - ALSPW
| Shareholder-services line|
Available Tuesday through Thursday
(10 a.m.-12 p.m.)
+33 (0)811 045 555
| Investor relations|